Immuneering Corp (IMRX)
2.25
+0.05
(+2.27%)
USD |
NASDAQ |
Dec 24, 16:00
Immuneering Free Cash Flow: -52.51M for Sept. 30, 2024
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Amicus Therapeutics Inc | -31.51M |
| PTC Therapeutics Inc | -274.19M |
| AN2 Therapeutics Inc | -61.05M |
| NovaBay Pharmaceuticals Inc | -4.812M |
| Palatin Technologies Inc | -32.57M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -13.47M |
| Cash from Investing (Quarterly) | -5.415M |
| Cash from Financing (Quarterly) | 4.365M |
| Free Cash Flow Per Share (Quarterly) | -0.4516 |
| Free Cash Flow Yield | -79.02% |